05:22 PM EST, 12/11/2024 (MT Newswires) -- Mark J Gergen, Director, Executive Chairman, on December 10, 2024, sold 30,000 shares in Poseida Therapeutics ( PSTX ) for $283,866. Following the Form 4 filing with the SEC, Gergen has control over a total of 651,291 shares of the company, with 651,291 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1661460/000095017024135466/xslF345X05/ownership.xml